Artiva aims for $116M in second attempt at IPO to boost NK cell therapy pipeline

Clinical-stage cell therapy developer Artiva Biotherapeutics will seek about $116 million in net proceeds from its proposed initial public offering, according to an updated SEC …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Evotec presents precision medicine platforms for accelerated pipeline building at Capital Markets Day – Biotech Investments

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec presents precision medicine platforms for accelerated pipeline building at Capital Markets Day 15.11.2023 / 07:30 CET/CEST The

November 16, 2023

New PET imaging biomarker Gal-1 predicts tumor responses to immunotherapy

The protein galectin-1 (Gal-1) has been identified as a new PET imaging biomarker for immune checkpoint blockade (ICB) therapy, allowing physicians to predict the tumor

May 15, 2024

Steve Jobs’ son to lead Emerson Collective’s oncology-focused VC firm Yosemite

Emerson Collective, the VC firm from billionaire Laurene Powell Jobs, has formed an oncology-focused investment fund that will be led by Reed Jobs, her son

August 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.